337535-94-1

Basic information

• Product Name: 6-BROMO-N-METHYLPICOLINAMIDE
• Synonyms: 6-Bromo-N-methyl-2-pyridinecarboxamide
• CAS NO: 337535-94-1
• Molecular Formula: C₇H₇BrN₂O
• Molecular Weight: 215.05
• Mol File: 337535-94-1.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 6-BROMO-N-METHYLPICOLINAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-N-METHYLPICOLINAMIDE(337535-94-1)
• EPA Substance Registry System: 6-BROMO-N-METHYLPICOLINAMIDE(337535-94-1)

Safety Data

• Hazardous Substances Data: 337535-94-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Chemical Research:
6-bromo-N-methylpicolinamide is used as a building block for the synthesis of various biologically active compounds, contributing to the advancement of medicinal chemistry and drug discovery efforts.
Used in Radiolabeled Compound Development:
6-bromo-N-methylpicolinamide is used as a precursor for the development of radiolabeled compounds, which are essential for imaging and diagnostic purposes in the medical field.
Used in Medicinal Chemistry:
6-bromo-N-methylpicolinamide is utilized as a versatile chemical in the design and synthesis of new pharmaceutical agents, enhancing the discovery of novel therapeutics.
Used in Drug Development:
6-bromo-N-methylpicolinamide is employed as a key component in the development of innovative drugs, potentially leading to breakthroughs in the treatment of various diseases and conditions.

Upstream product

• 21190-87-4 6-bromo-pyridine-2-carboxylic acid 
• 139487-69-7 6-bromopyridine-2-carbonyl chloride 
• 74-89-5 methylamine 

Downstream Products

• 337535-95-2 6-{4-[1-hydroxy-2-methyl-1-(1-trityl-1H-imidazol-4-yl)propyl]phenyl}-N-methyl-2-pyridinecarboxamide 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND USES THEREOF

Heterocyclic compounds as Wee1 inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

BENZOTHIAZOLE AND BENZOOXAZOLE DERIVATIVES AND METHODS OF USE

Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions of compounds of formula (I), methods for using such compounds and compositions, and a process for preparing the compounds.

1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof

To provide a composition having a steroid C17,20-lyase inhibitory activity and useful as an agent for the prophylaxis or treatment of prostatism and tumors such as breast cancer. A compound represented by the formula: wherein R is a hydrogen atom or a protecting group, R1is a lower alkyl group or a cyclic hydrocarbon group, R2is an aromatic hydrocarbon group optionally having substituents or an aromatic heterocyclic group optionally having substituents, R3is a hydrocarbon group optionally having substituents, a hydroxyl group optionally having substituents, a thiol group optionally having substituents, an amino group optionally having substituents, an acyl group or a halogen atom, and n is an integer of 0 to 4, and a salt thereof have a steroid C17,20-lyase inhibitory activity, and are useful as an agent for the pophylaxis or treatment of prostatism and tumors such as beast cancer and the like.